Earlier studies have indicated that PRSS22 contributes to cancer cell development in human hepatocellular carcinoma (16), that overexpression of PRSS22 facilitated the breast cancer cells invasion and that suppression of PRSS22 was restrictive (17). Here, PRSS22 is linked to breast carcinoma.